In the United States, the drug price for insulin has skyrocketed over the last two decades. While the price has increased for all forms of insulin, newer, "analogue" insulin medications such as glargine and lispro have become ...
Jan 29, 2019
0
9
(HealthDay)—Ensuring a short duration between dinner and bedtime has no effect on hemoglobin A1c (HbA1c) levels in middle-aged and older Japanese adults, according to a study published online Jan. 22 in BMJ Nutrition, Prevention ...
Jan 24, 2019
0
3
(HealthDay)—Many primary care patients are not given tests recommended for monitoring diabetes, according to a study published in the December issue of Family Medicine and Community Health.
Jan 11, 2019
0
8
(HealthDay)—Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according ...
Jul 13, 2018
0
0
(HealthDay)—For non-pregnant adults with type 2 diabetes, hemoglobin A1c (HbA1c) targets should be personalized, according to a Clinical Guidelines Synopsis published in the June 19 issue of the Journal of the American ...
Jun 20, 2018
0
1
(HealthDay)—Limited food access owing to cost (food insecurity) is associated with increased hemoglobin A1c (HbA1C) among patients with diabetes, according to a study published online March 19 in Diabetes Care.
Mar 23, 2018
0
6
(HealthDay)—Prediabetes defined by hemoglobin A1c (HbA1c) is associated with worse prognosis than definition by fasting plasma glucose (FPG) or two-hour plasma glucose (2hPG), according to a study published online Feb. ...
Feb 22, 2018
0
12
A newly published study has shown that an individualized approach to nutritional ketosis (utilizing fat rather than glucose to fuel the body), combined with remote monitoring via a mobile application, could sustainably and ...
Feb 7, 2018
0
736
An ethnic population at high risk for Type 2 diabetes achieved significant control of the disease through participation in community-based health programs, demonstrating that active intervention and culturally-sensitive education ...
Jan 31, 2018
0
9
(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.
Dec 26, 2017
0
6
